Cancer Research ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
| | | | We’ve renewed funding for our Clinical Academic Training Programme. Nine locations across the UK will receive £58.7m over the next 5 years to deliver an integrated training programme for clinicians pursuing an academic career.
The programme helps to attract and retain early-career clinical academic researchers by offering a greater variety of training options and providing holistic support before, during and after training. Following a successful first 5 years, the renewed funding will support a further 260 students through the clinical academic training. |
| | |
| | |
|
|
|
|
Funding & Research Opportunities |
| Get in touch with our office for confidential advice on eligibility, remit and funding options prior to applying. |
|
| | | | | | | | Applications accepted all year round |
|
|---|
| | | | | | Applications accepted all year round |
|
|---|
| | | | | | Applications accepted all year round |
|
|---|
| | | | | | Applications accepted all year round |
|
|---|
|
| | |
|
|
Thank you for letting us know your research outcomes |
| A huge thank you to all our CRUK-funded researchers and students who’ve taken the time and care to submit your research outcomes during the annual reporting period.
Over the past 12 months, your work has led to around 9,800 publications and 1,400 new collaborations, which is more than double what you reported last year. Not only that, but the total amount of further funding reported was triple that of last year.
The information you shared is crucial to evaluate and shape how we work and how we communicate the impact of our investment in pioneering research. |
| | |
|
|
|
Deepen your understanding of risks with us in Boston |
| Do you want to learn more about cancer risks?
At our Cancer Prevention Research Conference in Boston this June, Sapna Syngal (Dana Farber Cancer Institute) and Rudolf Kaaks (DKFZ / German Cancer Research Centre) will chair a session on the confluence of various risk factors at an individual and population level.
You can also hear from Neeha Zaidi (John Hopkins University), Tuya Pal (Vanderbilt University Medical Center), Anneke Lucassen (Oxford University) and Mathias Heikenwälde (DKFZ / German Cancer Research Centre) on how to better identify those at higher risk who would therefore benefit from preventive intervention.
In the meantime, don’t forget to follow along #PrevConf24 on our socials for more updates. |
| | |
|
|
|
| | | | The Experimental Cancer Medicine Centre network is hosting a webinar dedicated to teenage and young adult cancers, on 30 April from 3 – 4 pm.
This interactive webinar will address key topics ranging from clinical trial access, design and delivery, to patient perspectives on the importance of considering this age group in clinical research.
Join Dan Stark (University of Leeds) and Gillian Horne (University of Glasgow) to hear some exemplary projects and their experience of working with teenagers and young adults affected by cancer. | | |
| | | | | | Are you working or interested in AI use in oncology? The European Association for Cancer Research (EACR) and EuCanImage are co-hosting a workshop – Trustworthy Artificial Intelligence in Multi-Country Cancer Imaging – on 10 June in Rotterdam, Netherlands.
Based on experiences from the Horizon 2020 EuCanImage project, the workshop discusses clinical and technical considerations of trustworthy AI in multi-country oncology imaging.
You will have the opportunity to gain hands-on experience with the 25,000-sample EuCanImage data collection, discuss potential use cases that can be built based on this data collection and explore the EuCanImage breast cancer dataset. | | |
|
|---|
|
|
|
|
| | | “The commonest concern is the balance between clinical and research time, and how to ensure protected research time away from the clinic” |
| | Clinician scientists are vital to the success of cancer research, bridging the gap between discovery science and patients. We spoke to Iain McNeish, Chair of Oncology at Imperial College London about the need to entice, and keep, medics in cancer research and what CRUK are doing to grow the clinical academic community. |
| | |
|
|
|---|
|
|
|
|
|
Beatson International Cancer Conference |
| Join the 25th Beatson International Cancer Conference from 8-11 July at the Cancer Research UK Scotland Institute in Glasgow.
Allan Balmain (University of California, San Francisco), Karen Cichowski (Harvard University), Tyler Jacks (The Massachusetts Institute of Technology) and Ashani Weeraratna (John Hopkins Bloomberg School of Public Health) will be Keynote speakers.
The conference will fall broadly within a number of key areas ranging from the development of sophisticated allele-specific and tissue-specific animal models to their use in the study of specific cancer types, the engagement of tumour with immune cells and the microenvironment, metastatic disease and therapeutic resistance.
Deadline for abstract submission is 3 May, they’d especially like to hear from you if you are an early career researcher. |
| | |
|
|
|
What did you think of this email? |
|
| | |
|
|
| | Together we are
beating cancer |
| | |
|---|
|
|
|
| | You are playing a crucial role in helping us beat cancer sooner, so we'd like to continue to keep you updated on what we're up to. You can manage your preferences and unsubscribe here.
Your details are safe with us. Check out our Privacy Policy.
Our supporters are at the heart of everything we achieve at Cancer Research UK. Read our Fundraising Promise.
This email is from Cancer Research UK. Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666), the Isle of Man (1103) and Jersey (247). A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F). Registered address: 2 Redman Place, London, E20 1JQ. |
|
|
|
